Peyronies Society Forums

Please login or register.

Login with username, password and session length
Advanced search  

News:

We offer our most sincere condolences to Old Man who lost his wife of 59 years on Monday night to Pancreatic Cancer.   
He is in our sincere thoughts and prayers.

Pages: [1]   Go Down

Author Topic: New VED Study 3/30/20  (Read 2962 times)

0 Members and 1 Guest are viewing this topic.

NeoV

  • Major Contributor
  • ****
  • Country: jp
  • Offline Offline
  • Gender: Male
  • Posts: 2176
    • Neoman
New VED Study 3/30/20
« on: April 03, 2020, 06:03:51 AM »

https://www.ncbi.nlm.nih.gov/pubmed/32223874

RESULTS:
Fifty-three patients met the inclusion criteria. The mean (standard deviation [SD]) age was 57 (12) years, and the mean (SD) duration of Peyronies Disease prior to assessment was 25 (15) months. The mean (SD) duration of followup was 14 (11) months. Among untreated patients who did not use a VED, nine showed improvement, 20 remained stable, and four had worsening curvature. The untreated group had a significant change in curvature, with a mean improvement (SD) of 3.6 (12)º (p=0.048). All 20 men who initiated VED traction therapy had an improvement in curvature with a significant mean (SD) improvement of 23 (16)º (p=2.6×10-6). Changes in SHIM scores did vary significantly between groups. No complications were noted.

CONCLUSIONS:
In patients who opt for non-invasive management of Peyronies Disease, VED traction therapy provides improved curvature resolution compared to those who do not use such a device. The limitations of this study include the retrospective nature and a small sample size at a single treatment center.
Pages: [1]   Go Up
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
8599 Views
Last post July 04, 2010, 10:45:07 PM
by Hawk
15 Replies
3455 Views
Last post September 04, 2017, 03:08:05 AM
by james1947
7 Replies
701 Views
Last post January 06, 2022, 02:48:31 AM
by PeyroniKirai